View Post

Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials

In Clinical Trials by Barbara Jacoby

From: Feasibility Study Intends to Quantify PRP’s Active Ingredients in Human Serum Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that it has initiated development of a bio-analytical assay intended to quantify the active ingredients of the company’s lead product candidate, PRP, in preparation …